kalshiMarch 31, 20261d agoTrump-China Free Trade Agreement by Jan 2029
Will Trump make a new free trade agreement with China before Jan 20, 2029?
Signal
SELL
Probability
8%
Confidence
HIGH
82%
Summary.
The market is significantly overpriced at 35.5% compared to my estimated probability of 8%. The core issue is that the resolution criteria requires an FTA to "become law," which constitutionally mandates congressional ratification—not merely an executive agreement or transactional framework. As of March 31, 2026, multiple recent developments point away from a comprehensive FTA: the Supreme Court's February 20 tariff ruling eliminated Trump's unilateral trade tools; the March 2 USTR agenda emphasizes "managed trade" with zero mention of a China FTA; and new Section 301 investigations launched March 11-13 represent escalation rather than détente. The bipartisan anti-China consensus (evidenced by the BIOSECURE Act) creates near-insurmountable ratification barriers, while Trump's own January 2026 threat against Canada over a potential China FTA reveals ideological opposition to free trade with China. The market appears to be conflating transactional deals (like the October 2025 Busan Framework) with actual FTAs, underweighting the congressional ratification requirement, and ignoring the zero historical base rate for US-China comprehensive FTAs. Even the upcoming May 2026 Beijing summit is expected to produce Boeing/agricultural deals, not FTA negotiations. With China's share of US imports having collapsed from 22% to 9% and a 28% decline in 2025 alone, the fundamental trajectory is decoupling, not integration.
Reasoning.
Step 1: Define the Resolution Criteria The market resolves YES if "a new free trade agreement with China has become law before January 20, 2029." This is critical: the FTA must "become law," which constitutionally requires congressional ratification. Executive agreements or transactional frameworks (like the 2020 Phase One Deal or 2025 Busan Framework) do not constitute "law" under standard FTA legal interpretation.
Step 2: Assess Current Political and Legal Landscape (March 31, 2026)
- Supreme Court struck down Trump's tariff authority on Feb 20, 2026 (6-3 ruling), forcing pivot to Section 301 investigations
- USTR 2026 Trade Agenda (March 2, 2026) emphasizes "Agreements on Reciprocal Trade" and "managed trade" - no mention of China FTA
- New Section 301 investigations launched March 11-13, 2026, representing escalation not détente
- Bipartisan anti-China consensus evidenced by BIOSECURE Act passage
- Trump threatened Canada with 100% tariff in Jan 2026 over potential China FTA, showing ideological opposition to free trade with China
Step 3: Evaluate Historical Base Rate Base rate: 0%. The US has never had a comprehensive FTA with China. Previous "deals" (Phase One 2020, Busan Framework 2025) were managed trade agreements with purchase commitments, not FTAs eliminating tariff/non-tariff barriers.
Step 4: Assess Economic Reality
- China's share of US imports fell from 22% (pre-2018) to 9% (end 2025)
- US imports from China dropped 28% in 2025 alone
- This represents fundamental supply chain decoupling, not temporary friction
Step 5: Model Congressional Ratification Probability Even if Trump negotiated an FTA, congressional ratification faces severe obstacles:
- Bipartisan anti-China consensus (BIOSECURE Act, tech restrictions)
- No modern precedent for FTA ratification with geopolitical rival during tension period
- 2028 elections could shift Senate/House composition, but anti-China stance is bipartisan
- Timeline is tight: negotiate, draft, submit, debate, ratify by Jan 20, 2029
Step 6: Evaluate Upcoming May 2026 Beijing Visit Expected outcomes are transactional (Boeing purchases, agricultural deals, possible semiconductor easing), not comprehensive FTA. Even optimistic scenario produces framework agreement similar to Busan, which wouldn't meet resolution criteria.
Step 7: Consider Trump's Incentive Structure Trump's trade philosophy emphasizes bilateral deficits and "reciprocity," not free trade. His Jan 2026 threat to Canada over China FTA reveals ideological opposition. A true FTA (eliminating tariffs/barriers) contradicts his protectionist brand.
Step 8: Risk Adjustment
- Small probability (~5%) that crisis (Taiwan, economic collapse) forces dramatic policy shift
- Small probability (~3%) that resolution arbiter interprets "become law" loosely to include executive agreements (though this would be controversial)
- Negligible probability that Trump pivots to genuine free trade ideology
Final Estimate: 8% This accounts for tail-risk scenarios (geopolitical crisis, resolution ambiguity) while recognizing the fundamental political, legal, and ideological barriers make this outcome highly unlikely.
Market Comparison: Current market odds: 35.5% My estimate: 8% The market appears significantly overpriced, likely due to:
- Confusion between "trade deals" (frameworks, purchase agreements) and actual FTAs
- Overweighting Trump's transactional reputation without considering congressional ratification requirement
- Insufficient appreciation for bipartisan anti-China consensus
Key Factors.
Constitutional requirement for congressional ratification of FTAs (executive agreements insufficient)
Bipartisan anti-China consensus in Congress (BIOSECURE Act, tech restrictions, supply chain security)
Zero historical base rate for US-China comprehensive FTA
Trump's protectionist ideology and threats against allies pursuing China FTAs
Severe bilateral trade contraction (China share of imports: 22% → 9%, 28% decline in 2025)
Supreme Court tariff ruling (Feb 2026) removed Trump's unilateral trade tools, forcing Section 301 approach
USTR 2026 agenda emphasizes managed trade and reciprocity, not free trade expansion
Timeline constraint: ~33 months to negotiate, draft, and ratify complex FTA
Recent escalation via Section 301 investigations (March 2026) signals continued tension
Scenarios.
Base Case: No FTA
85%Trump continues transactional approach with China through purchase agreements and temporary frameworks (similar to Busan Framework Oct 2025). May 2026 Beijing summit produces Boeing/agricultural deals and semiconductor easing, but no comprehensive FTA. Congressional anti-China consensus prevents any FTA ratification attempt. Trade relationship remains managed/restricted.
Trigger: May 2026 summit produces transactional outcomes only. USTR continues Section 301 investigations. No FTA draft submitted to Congress by mid-2027. Bipartisan anti-China legislation continues (tech restrictions, supply chain security).
Crisis-Driven Détente
5%Major geopolitical or economic crisis (Taiwan near-conflict resolved via diplomacy, global financial crisis, pandemic) forces dramatic US-China rapprochement. Trump negotiates comprehensive FTA as part of broader stabilization package. Congressional leadership whips votes for ratification citing national emergency. FTA becomes law by late 2028.
Trigger: Major crisis event in 2026-2027 requiring US-China cooperation. Bipartisan foreign policy establishment supports deal. Senate leadership (McConnell/Schumer successors) commit to ratification. Trump makes FTA centerpiece of 2028 re-election campaign or legacy agenda.
Resolution Ambiguity Scenario
3%Trump negotiates executive agreement (not congressional FTA) that market arbiter controversially interprets as meeting 'become law' criteria. This would be legally dubious but possible if arbiter uses loose interpretation. More likely: Trump announces 'historic FTA' that is actually framework agreement, creating resolution dispute.
Trigger: Executive agreement signed with 'Free Trade Agreement' in title. Market arbiter faces pressure to resolve YES based on naming rather than legal substance. Congressional Republicans argue executive agreement has force of law.
Trump Ideological Pivot
7%Trump makes unexpected pivot to genuine free trade position, possibly influenced by business constituency or economic advisors. Negotiates actual FTA and expends political capital for congressional ratification. Faces Republican rebellion but secures Democratic votes. This contradicts his entire political brand and protectionist base.
Trigger: Trump replaces trade team with free-trade advocates. Major speech announcing China FTA initiative. Business community (Chamber of Commerce, tech sector) lobbies heavily. Trump frames FTA as 'greatest deal ever made' to sell to base.
Risks.
May 2026 Beijing summit could produce unexpected breakthrough (though likely transactional only)
Resolution arbiter might interpret 'become law' loosely to include executive agreements (legally dubious)
Major geopolitical crisis (Taiwan, Korea, economic collapse) could force dramatic policy realignment
Underestimating Trump's deal-making unpredictability and willingness to contradict prior positions
2028 election outcome could shift congressional composition, though anti-China stance is bipartisan
Potential for Trump to rebrand managed trade agreement as 'FTA' creating resolution ambiguity
China could offer unprecedented concessions (IP protection, market access, labor standards) making FTA politically viable
Analysis assumes continuation of current US-China decoupling trend, which could reverse
Missing information about May 2026 summit outcomes (40 days away) introduces uncertainty
Edge Assessment.
STRONG EDGE: Market is significantly overpriced at 35.5% vs. my estimate of 8%.
This represents a 27.5 percentage point mispricing. The market appears to be:
-
Conflating trade deals with FTAs: The Busan Framework (Oct 2025) and expected May 2026 transactional agreements are not FTAs. True FTAs eliminate tariff/non-tariff barriers and require congressional ratification.
-
Underweighting congressional ratification barrier: Even if Trump wanted an FTA (which contradicts his ideology), the bipartisan anti-China consensus makes ratification nearly impossible. BIOSECURE Act passage demonstrates this.
-
Ignoring legal requirement: Resolution criteria states FTA must "become law." Executive agreements don't meet this threshold under standard legal interpretation.
-
Overweighting Trump's reputation: While Trump is transactional, his trade philosophy is protectionist. His Jan 2026 threat to Canada over China FTA reveals genuine opposition to free trade with China.
-
Ignoring base rate: Zero historical precedent for US-China FTA. Phase One Deal (2020) was purchase agreement, not FTA.
Recommended position: The NO side offers significant value. Fair odds should be around 8-12%, making current 35.5% substantially mispriced. This is high-conviction edge based on constitutional law, political reality, and historical precedent.
Caveat: Watch May 2026 Beijing summit closely. If Trump announces FTA negotiations (unlikely), reassess. But even then, congressional ratification remains formidable barrier.
What Would Change Our Mind.
May 2026 Beijing summit produces announcement of formal FTA negotiations (not just transactional deals) with Trump explicitly committing to pursue congressional ratification
Major geopolitical crisis (Taiwan conflict resolution, global financial crisis, pandemic) forcing dramatic US-China rapprochement with bipartisan foreign policy establishment supporting FTA
Congressional leadership from both parties publicly endorsing China FTA framework and committing to ratification process
Trump replaces trade team with free-trade advocates and makes major policy speech pivoting away from protectionism toward comprehensive China FTA
Clarification from market arbiter that executive agreements or framework deals would qualify as 'becoming law' under resolution criteria (though this would contradict standard FTA legal interpretation)
China offers unprecedented concessions on IP protection, forced technology transfer, market access, and labor standards that shift congressional cost-benefit calculus
Significant shift in 2026-2027 polling showing American public strongly supporting China FTA, changing political incentives for congressional ratification
Sources.
- Supreme Court Strikes Down Trump 2025 Tariffs (February 20, 2026)
- USTR 2026 Trade Policy Agenda (March 2, 2026)
- USTR Launches New Section 301 Investigations into China (March 11-13, 2026)
- US-China Bilateral Trade Statistics 2025
- Busan Framework Agreement (October 2025)
- Scheduled Trump Visit to Beijing (May 2026)
- BIOSECURE Act Passed in 2026 NDAA
- Trump Threatens Canada Over Potential China FTA (January 2026)
Get This Via API.
Access real-time prediction market analysis programmatically. Every analysis on this page is available through our REST API.
curl -X POST https://api.rekko.ai/v1/markets/kalshi/TICKER/analyze \ -H "Authorization: Bearer YOUR_API_KEY"
Related Analysis.
Fed Interest Rate Increase of 25+ bps After April 2026 Meeting
Based on analysis as of March 20, 2026, the probability of a 25+ bps Fed rate hike at the April 28-29 meeting is estimated at 1%, precisely matching the CME FedWatch market-implied probability. This represents near-universal consensus that a hike will NOT occur. The overwhelming evidence includes: (1) the March 17-18 FOMC dot plot showing zero of 12 participants projecting any rate increases in 2026, with median forecast indicating one 25 bps CUT by year-end; (2) the only dissent at the March meeting was Governor Miran voting for a CUT, not a hike; (3) Chair Powell's messaging emphasizing patience and viewing current 3.50%-3.75% rates as "sufficiently restrictive"; (4) inflation attributed to temporary supply shocks (tariffs, Middle East energy crisis) rather than demand overheating requiring tighter policy; and (5) the Fed having just completed a cutting cycle in late 2025, with historical precedent showing such pauses lead to holds or eventual cuts, not renewed tightening. Even the most hawkish mainstream analysts expect no hikes until 2027 at earliest. With only 39 days until the April meeting, there is insufficient time for the catastrophic inflation data that would be required to force a complete Fed policy reversal. The market is correctly priced with no identifiable edge.
Courts consider Amazon a monopoly?
The market assigns a 58.5% probability that a U.S. District Court will find Amazon illegally maintained a monopoly, while our analysis estimates 52%—a modest 6.5 percentage point discrepancy. The FTC's case has survived two dismissal attempts and benefits from a lengthy discovery period and favorable precedent (DOJ v. Google Search), but three factors suggest the market may be overconfident in a government victory: (1) Settlement risk is substantial—historical antitrust cases of this magnitude settle 40-60% of the time, and any settlement would resolve NO since it avoids a court monopoly finding; (2) FTC Chair Andrew Ferguson's less aggressive stance than predecessor Lina Khan may increase settlement pressure despite maintaining the case for 18+ months; (3) High evidentiary burdens at trial—surviving pleading-stage motions does not translate linearly to proving complex market definition and anticompetitive effects claims. Our scenario modeling assigns 35% probability to government trial victory, 33% to settlement (resolves NO), and 32% to Amazon trial victory. Confidence is low (0.45) due to significant information asymmetry: discovery evidence quality, settlement negotiation status, and Judge Chun's substantive views remain opaque to public markets. The 4-year timeline to 2030 resolution creates substantial intervening event risk.
Courts consider Amazon a monopoly?
The market prices FTC victory at 65%, while my analysis estimates 58% probability that Judge Chun will rule Amazon illegally maintained a monopoly. The FTC has strong procedural momentum: Judge Chun denied Amazon's motion to dismiss in September 2024 (a significant positive signal as most antitrust cases surviving this hurdle have elevated government success rates), and Amazon's $2.5 billion Prime settlement before the same judge in September 2025 suggests compelling internal discovery evidence and judicial receptiveness to government arguments about Amazon's practices. However, the market appears to overly discount critical risks. Market definition remains contested as evidenced by the March 7, 2026 economics hearing—if Amazon successfully argues the relevant market includes all retail (Walmart, Target, brick-and-mortar), its market share falls below monopoly thresholds and the case collapses regardless of conduct evidence. Historical base rates show ~50-60% government win rates in monopoly maintenance trials. While procedural strength justifies upward adjustment, the 65% market price exceeds what the evidence supports given ongoing market definition disputes, discovery still in progress through April 2026, and inherent unpredictability of bench trial outcomes. The 7-percentage-point gap represents a modest edge but meaningful mispricing.